Ignite Creation Date:
2024-05-05 @ 11:43 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00113802
Status:
TERMINATED
Last Update Posted:
2021-08-19
First Post:
2005-06-10
Brief Title:
Study of Epratuzumab hLL2 in Patients With Waldenstroms Macroglobulinemia
Sponsor:
Gilead Sciences
Organization:
Gilead Sciences
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Waldenstrom Macroglobulinemia |